(Q41721318)

8 October 2017

Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study (English)

1 reference

8 October 2017

0 references

1 reference

1 reference

Børge G. Nordestgaard

3

object named as

Børge Grønne Nordestgaard

0 references

Ask Tybjærg Nordestgaard

1

object named as

Ask Tybjærg Nordestgaard

0 references

author name string

Ask Tybjærg Nordestgaard

1

1 reference

8 October 2017

Mette Thomsen

2

1 reference

8 October 2017

Børge Grønne Nordestgaard

3

1 reference

8 October 2017

language of work or name

1 reference

1 April 2015

1 reference

International Journal of Epidemiology

8 October 2017

1 reference

8 October 2017

44

1 reference

8 October 2017

2

1 reference

8 October 2017

551-565

1 reference

Coffee and its consumption: benefits and risks

8 October 2017

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Effects of caffeine on human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Association of coffee drinking with total and cause-specific mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Coffee consumption and risk of type 2 diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Role of coffee in modulation of diabetes risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Coffee consumption and cardiovascular health: getting to the heart of the matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Genetically elevated C-reactive protein and ischemic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

The genetics of type 2 diabetes: what have we learned from GWAS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Changes in coffee intake and subsequent risk of type 2 diabetes: three large cohorts of US men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

Phenotype refinement strengthens the association of AHR and CYP1A1 genotype with caffeine consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYV083

21 January 2018

Identifiers

DOI

10.1093/IJE/DYV083

1 reference

8 October 2017

1 reference